tiprankstipranks
Advertisement
Advertisement

ABEO Stock Latest News

Abeona Therapeutics Highlights Strong ZEVASKYN Launch Momentum
Company AnnouncementsAbeona Therapeutics Highlights Strong ZEVASKYN Launch Momentum
13d ago
ABEO
Abeona Therapeutics Signals Strong Early ZEVASKYN Launch
PremiumCompany Announcements
Abeona Therapeutics Signals Strong Early ZEVASKYN Launch
19d ago
ABEO
Abeona Therapeutics reports Q1 EPS (30c), consensus (39c)
PremiumThe Fly
Abeona Therapeutics reports Q1 EPS (30c), consensus (39c)
19d ago
ABEO
ABEO Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ABEO Upcoming Earnings Report: What to Expect?
21d ago
ABEO
Abeona Therapeutics Adds Keith Goldan to Board, Audit Chair
PremiumCompany Announcements
Abeona Therapeutics Adds Keith Goldan to Board, Audit Chair
2M ago
8K
ABEO
Abeona Therapeutics Tightens Shareholder Meeting and Governance Rules
PremiumCompany AnnouncementsAbeona Therapeutics Tightens Shareholder Meeting and Governance Rules
2M ago
8K
ABEO
Early-Stage ZEVASKYN Momentum and Attractive Economics Underscore Abeona’s Undervalued Growth Potential and $20 Buy Rating
Premium
Ratings
Early-Stage ZEVASKYN Momentum and Attractive Economics Underscore Abeona’s Undervalued Growth Potential and $20 Buy Rating
2M ago
ABEO
Abeona Therapeutics Balances Big Windfall With Slow Ramp
Premium
Company Announcements
Abeona Therapeutics Balances Big Windfall With Slow Ramp
3M ago
ABEO
Abeona Therapeutics price target lowered to $20 from $27.50 at Alliance Global
PremiumThe Fly
Abeona Therapeutics price target lowered to $20 from $27.50 at Alliance Global
3M ago
ABEO
Options Volatility and Implied Earnings Moves Today, March 17, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 17, 2026
3M ago
ASO
TME
Abeona Therapeutics reports 2025 EPS $1.01 vs. ($1.55) last year
PremiumThe Fly
Abeona Therapeutics reports 2025 EPS $1.01 vs. ($1.55) last year
3M ago
ABEO
Options Volatility and Implied Earnings Moves This Week, March 16 – March 20, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, March 16 – March 20, 2026
3M ago
M
MU
ABEO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsABEO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
ABEO
Early ZEVASKYN Launch Traction and Robust Reimbursement Support Abeona Buy Rating and $20 Target
Premium
Ratings
Early ZEVASKYN Launch Traction and Robust Reimbursement Support Abeona Buy Rating and $20 Target
3M ago
ABEO
Abeona Accelerates ZEVASKYN Commercial Momentum and Market Access
Premium
Company Announcements
Abeona Accelerates ZEVASKYN Commercial Momentum and Market Access
3M ago
8K
ABEO
Abeona Therapeutics provides business update on momentum in Zevaskyn launch
PremiumThe Fly
Abeona Therapeutics provides business update on momentum in Zevaskyn launch
3M ago
ABEO
3 Best Stocks to Buy Today, 2/3/2026, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Today, 2/3/2026, According to Top Analysts
4M ago
ABEO
AFRM
Abeona Therapeutics: Advancing UX111 Toward First-to-Market Approval and Scaling ZEVASKYN Launch to Near-Term Profitability
PremiumRatings
Abeona Therapeutics: Advancing UX111 Toward First-to-Market Approval and Scaling ZEVASKYN Launch to Near-Term Profitability
4M ago
ABEO
Aehr, Fastenal, Regions, Abeona, Taysha: Insider Firestorm
PremiumWeekend Updates
Aehr, Fastenal, Regions, Abeona, Taysha: Insider Firestorm
4M ago
RF
ABEO
Dave & Buster’s, American Eagle, Cabaletta, Abeona, Oncolytics Insider Shock
PremiumWeekend UpdatesDave & Buster’s, American Eagle, Cabaletta, Abeona, Oncolytics Insider Shock
4M ago
AEO
ABEO
Abeona Therapeutics announces employee inducement grants
Premium
The Fly
Abeona Therapeutics announces employee inducement grants
5M ago
ABEO
Abeona Therapeutics appoints Mohamad Tabrizi as CBO
Premium
The Fly
Abeona Therapeutics appoints Mohamad Tabrizi as CBO
6M ago
ABEO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >